Jan D. Lünemann - Concepedia

Author

Jan D. Lünemann

Also Known As

Andeas Linsa, Andreas Linsa, Catherine Lomen-Hoerth, David A. Brown, Halime Gül, J D Lunemann, J D Lünemann, J Lunemann, J. D. Lunemann, J. D. Lünemann

195

Publications

11.3K

Citations

H-Index

Concepts

All Affiliations

University of Zurich Charité - Universitätsmedizin Berlin Rockefeller University University Hospital Münster University Hospital of Zurich

About

Jan D. Lünemann is an author at University of Zurich specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	23	1.6K
2	Allergy	5	5	206
3	Health Sciences	1	1	31
4	Law	1	1	67
5	Natural Sciences	1	1	15

Jan D. Lünemann

Publications

Citations

H-Index

Page 1

	Year	Citations
EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2 Jan D. Lünemann, Ilijas Jelčić, Susanne Roberts, The Journal of Experimental Medicine	2008	312
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity Isaak Quast, Christian W. Keller, Michael Maurer, Journal of Clinical Investigation ImmunologyImmune RegulationCell DeathImmunologic MechanismImmunotherapeutics	2015	260
Impaired inhibitory Fcγ receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy Björn Tackenberg, Ilijas Jelčić, Anne Baerenwaldt, Proceedings of the National Academy of Sciences	2009	239
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study Vera Bril, Artur Drużdż, Julian Großkreutz, The Lancet Neurology Clinical TrialsGeneralised Myasthenia GravisPharmacotherapyMedicineAnesthesiology	2023	227
Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis Jan D. Lünemann Brain Adaptive Immune SystemT-regulatory CellImmunologyImmunodominancePathology	2006	226
Elevated Epstein–Barr virus‐encoded nuclear antigen‐1 immune responses predict conversion to multiple sclerosis Jan D. Lünemann, Mar Tintoré, Brady Messmer, Annals of Neurology	2009	225
Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity Benjamin Peschke, Christian W. Keller, Patrick Weber, Frontiers in Immunology	2017	207
TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis Klaus‐Peter Wandinger, Jan D. Lünemann, Oliver Wengert, The Lancet CytokineAutoimmune DiseaseMedicineApoptosisImmunology	2003	206
A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis Manuel Comabella, Jan D. Lünemann, Jordi Río, Brain	2009	202
Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis Franziska Thaler, Luise Zimmermann, Stefan Kammermeier, Neurology Neuroimmunology & Neuroinflammation	2021	158

Page 1